Patents by Inventor Jill Hutchinson Bollettieri

Jill Hutchinson Bollettieri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glycoside compounds and pharmaceutical compositions thereof
    Patent number: 8703723
    Abstract: The present invention provides glycoside compounds, methods of preparing such compounds, pharmaceutical compositions comprising such compounds, and a method for the treatment of hyperproliferative diseases using the same.
    Type: Grant
    Filed: December 27, 2012
    Date of Patent: April 22, 2014
    Assignee: Centrose, LLC
    Inventor: Jill Hutchinson-Bollettieri
  • GLYCOSIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
    Publication number: 20130178431
    Abstract: The present invention provides glycoside compounds, methods of preparing such compounds, pharmaceutical compositions comprising such compounds, and a method for the treatment of hyperproliferative diseases using the same.
    Type: Application
    Filed: December 27, 2012
    Publication date: July 11, 2013
    Applicants: CENTROSE, LLC
    Inventor: Jill Hutchinson-Bollettieri
  • Extracellular targeted drug conjugates
    Patent number: 8470980
    Abstract: The present invention relates to, inter alia, extracellular drug conjugates (EDC) in which an antibody or other targeting agent (e.g. a targeting moiety) is linked to a drug through a linker (e.g. a non-cleavable linker). These conjugates are useful in the treatment of disease and/or as a tool in the evaluation of biological systems.
    Type: Grant
    Filed: September 9, 2010
    Date of Patent: June 25, 2013
    Assignee: Centrose, LLC
    Inventors: James R. Prudent, Jon S. Thorson, Jill Hutchinson Bollettieri
  • Glycoside compounds and pharmaceutical compositions thereof
    Patent number: 8361973
    Abstract: The present invention provides glycoside compounds, methods of preparing such compounds, pharmaceutical compositions comprising such compounds, and a method for the treatment of hyperproliferative diseases using the same.
    Type: Grant
    Filed: August 7, 2009
    Date of Patent: January 29, 2013
    Assignee: Centrose, LLC
    Inventors: Mohammed S. Shekhani, James R. Prudent, Jill Hutchinson Bollettieri
  • EXTRACELLULAR TARGETED DRUG CONJUGATES
    Publication number: 20110064752
    Abstract: The present invention relates to, inter alia, extracellular drug conjugates (EDC) in which an antibody or other targeting agent (e.g. a targeting moiety) is linked to a drug through a linker (e.g. a non-cleavable linker). These conjugates are useful in the treatment of disease and/or as a tool in the evaluation of biological systems.
    Type: Application
    Filed: September 9, 2010
    Publication date: March 17, 2011
    Applicant: CENTROSE, LLC
    Inventors: Charles R. Hutchinson, Jill Hutchinson Bollettieri, James R. Prudent, Jon S. Thorson